SomaLogic Inc.’s SLGC stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with Standard ...
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (LAB) (Standard BioTools or the Company), driven by a bold purpose – Unleashing tools to accelerate breakthroughs ...
Hosted on MSN
Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships
CEO Michael Egholm highlighted that Standard BioTools delivered Q1 2025 revenues of $40.8 million, aligned with their plan despite a challenging operating backdrop. He emphasized improvements in ...
Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights Expands commercial reach with substantial cross-selling ...
Standard BioTools, is engaged in product rationalization, cost-cutting and operational efficiency measures in an attempt to turn its business around and transition to profitability. The company’s ...
(RTTNews) - Wednesday, Standard BioTools Inc. (LAB) announced a collaboration agreement with Navignostics AG to develop clinical research applications and service offerings using the Hyperion XTi ...
Standard BioTools (NASDAQ:LAB) shares jumped as much as 19% premarket on Monday after the company announced the sale of its SomaLogic business to Illumina (NASDAQ:ILMN) for an aggregate cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback